Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123675703 | 12367570 | 3 | F | 201604 | 20160830 | 20160513 | 20160906 | EXP | KR-JNJFOC-20160509953 | JANSSEN | 62.18 | YR | A | M | Y | 64.20000 | KG | 20160906 | MD | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123675703 | 12367570 | 1 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | U | 0 | 1.3 | MG/M**2 | LYOPHILIZED POWDER | ||||||
| 123675703 | 12367570 | 2 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | U | 50718 | 30 | MG/M**2 | LIPOSOME INJECTION | ||||||
| 123675703 | 12367570 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 | 40 | MG | UNSPECIFIED | |||||||
| 123675703 | 12367570 | 4 | SS | IXAZOMIB | IXAZOMIB | 1 | Oral | 1041420 | 0 | 4 | MG | CAPSULE | |||||||
| 123675703 | 12367570 | 5 | SS | IXAZOMIB | IXAZOMIB | 1 | Oral | 1041420 | 0 | 3 | MG | CAPSULE | |||||||
| 123675703 | 12367570 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | MG | UNSPECIFIED | BID | |||||||
| 123675703 | 12367570 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 100 | MG | UNSPECIFIED | BID | |||||||
| 123675703 | 12367570 | 8 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | BID | |||||||
| 123675703 | 12367570 | 9 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | QD | |||||||
| 123675703 | 12367570 | 10 | C | VIMOVO | ESOMEPRAZOLE MAGNESIUMNAPROXEN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 123675703 | 12367570 | 11 | C | COLCHICINE. | COLCHICINE | 1 | Oral | 0 | .6 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123675703 | 12367570 | 1 | Plasma cell myeloma |
| 123675703 | 12367570 | 2 | Plasma cell myeloma |
| 123675703 | 12367570 | 3 | Plasma cell myeloma |
| 123675703 | 12367570 | 4 | Plasma cell myeloma |
| 123675703 | 12367570 | 5 | Plasma cell myeloma |
| 123675703 | 12367570 | 6 | Anaemia |
| 123675703 | 12367570 | 7 | Prophylaxis |
| 123675703 | 12367570 | 8 | Prophylaxis |
| 123675703 | 12367570 | 9 | Prophylaxis |
| 123675703 | 12367570 | 10 | Prophylaxis |
| 123675703 | 12367570 | 11 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123675703 | 12367570 | HO |
| 123675703 | 12367570 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123675703 | 12367570 | Anaemia | |
| 123675703 | 12367570 | Tumour lysis syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123675703 | 12367570 | 1 | 20160421 | 0 | ||
| 123675703 | 12367570 | 2 | 20160421 | 0 | ||
| 123675703 | 12367570 | 3 | 20160421 | 0 | ||
| 123675703 | 12367570 | 4 | 20160411 | 0 | ||
| 123675703 | 12367570 | 5 | 20151223 | 0 | ||
| 123675703 | 12367570 | 6 | 20150501 | 0 | ||
| 123675703 | 12367570 | 7 | 20160212 | 20160506 | 0 | |
| 123675703 | 12367570 | 8 | 20160316 | 20160420 | 0 | |
| 123675703 | 12367570 | 9 | 20160420 | 0 | ||
| 123675703 | 12367570 | 10 | 20160420 | 20160421 | 0 | |
| 123675703 | 12367570 | 11 | 20160420 | 20160422 | 0 |